Pill Identifier App

Ismelin Side Effects

Generic Name: guanethidine

Note: This page contains side effects data for the generic drug guanethidine. It is possible that some of the dosage forms included below may not apply to the brand name Ismelin.

It is possible that some side effects of Ismelin may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to guanethidine: oral tablet

Along with its needed effects, guanethidine (the active ingredient contained in Ismelin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking guanethidine:

More common
  • Swelling of feet or lower legs
Less common or rare
  • Chest pain
  • shortness of breath

Some side effects of guanethidine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common
  • Diarrhea or increase in bowel movements
  • dizziness, lightheadedness, or fainting, especially when getting up from a lying or sitting position
  • sexual problems in males
  • slow heartbeat
  • stuffy nose
  • unusual tiredness or weakness
Less common or rare
  • Blurred vision
  • drooping eyelids
  • dryness of mouth
  • headache
  • loss of hair on scalp
  • muscle pain or tremors
  • nausea or vomiting
  • nighttime urination
  • skin rash

For Healthcare Professionals

Applies to guanethidine: oral tablet

Cardiovascular

The risk of orthostatic hypotension, sometimes followed by syncope, is greatest within the first 10 minutes after dosing, early in the morning, and in hypovolemic patients. It is accentuated by alcohol, hot weather, or exercise--all of which are associated with peripheral vasodilation. The manufacturer recommends that guanethidine (the active ingredient contained in Ismelin) be gradually withdrawn over at least two weeks prior to administration of general anesthetics to avoid cardiovascular collapse during induction.

Cardiovascular side effects can result from excessive sympathetic blockade or a relative increase in parasympathetic tone. Orthostatic hypotension is reported in approximately 15% of patients, some of whom experience syncope.

Unopposed or excessive parasympathetic tone can cause excessive bradycardia in rare cases. This may cause serious problems in patients with underlying sinus node dysfunction.

Guanethidine can cause generalized edema in 10% to 15% of patients. Some patients with preexisting congestive heart failure do not tolerate this, and require concomitant diuretic therapy.

Gastrointestinal

Gastrointestinal side effects are also related to increased parasympathetic tone. Diarrhea is reported in 11% of patients, some of whom discontinued therapy because of it. Dry mouth or parotid tenderness are reported in approximately 5% of patients.

Genitourinary

There is evidence that guanethidine (the active ingredient contained in Ismelin) may interfere with ejaculation by inhibiting contraction of the seminal vesicle, ampula and ductus deferens.

Large studies report sexual impotence as a relatively uncommon genitourinary complaint, occurring in only approximately 2% of male patients. Smaller studies, where specific questions were asked of male patients reveal an incidence of impotence as high as 60%. Delayed or retrograde ejaculation and decreased sperm counts are reported. Impotence appears to be reversible upon discontinuation of therapy or reduction in dosage.

Respiratory

A relatively common respiratory system complaint, nasal stuffiness in up to 30% of patients, is related to increased parasympathetic tone. Rare reports of dyspnea or exertion unaccompanied by other signs or symptoms of congestive heart failure are associated with guanethidine (the active ingredient contained in Ismelin)

Renal

In one study, 58% of patients with or without preexisting elevated BUN developed an increase in the BUN during guanethidine (the active ingredient contained in Ismelin) therapy. The study did not, however, quantify the rise in BUN, attempt to make an association with the degree of blood pressure control, or attempt to measure other parameters of renal function.

Nervous system

Because guanethidine (the active ingredient contained in Ismelin) does not affect the central nervous system, neurologic side effects are notably either absent or infrequent. Insomnia and weakness are occasionally reported more often with guanethidine than with placebo.

Hypersensitivity

Hypersensitivity reactions are not associated with guanethidine (the active ingredient contained in Ismelin)

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web5)